Evaluation of the potential of transferrin-adriamycin conjugates in the treatment of bladder cancer

British Journal of Urology

Volumn 82, Issue 2, 1998, Pages 284-289

  Munns, J ^a   Yaxley, J ^a   Coomer, J ^a   Lavin, M F ^a   Gardiner, R A ^a   Watters, D ^a  

^a UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

Adriamycin resistance; Bladder cancer; Transferrin adriamycin conjugates

Indexed keywords

ANTHRACYCLINE ANTIBIOTIC AGENT; DOXORUBICIN; TRANSFERRIN; TRANSFERRIN RECEPTOR;

ANIMAL CELL; ARTICLE; BLADDER CANCER; CELL LINE; CELL SURVIVAL; CHO CELL; DRUG CYTOTOXICITY; DRUG TARGETING; GROWTH INHIBITION; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; ANTIBIOTICS, ANTINEOPLASTIC; CELL SURVIVAL; CRICETINAE; DOSE-RESPONSE RELATIONSHIP, DRUG; DOXORUBICIN; DRUG CARRIERS; DRUG COMBINATIONS; DRUG RESISTANCE, NEOPLASM; HUMANS; NEOPLASM TRANSPLANTATION; TRANSFERRIN; TUMOR CELLS, CULTURED; URINARY BLADDER NEOPLASMS;

EID: 0031855445     PISSN: 00071331     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1464-410X.1998.00736.x     Document Type: Article

References (21)

1. Waring MJ. DNA-modification and cancer. Ann Rev Biochem 1981; 50: 159-92
2. Sun IL. Crane FL. Interactions of antitumour drugs with plasma membranes. In Crane FL, Morre DJ. Low HE, eds, Oxidoreduction at the plasma membrane: relation to growth and transport, Vol I. Chapt 14. Boca Raton: CRC Press, 1990: 257-80
3. Zweier JL. Reduction of 02 by iron-adriamycin. J Biol Chem 1984: 259: 6056-8
4. Fritzer M, Barabas K. Szuts V et al. Cytotoxicity of a transferrin-adriamycin conjugate to anthracycline-resistant cells. Int }Cancer 1992: 52: 619-23
5. Pastan I. Gottesmann MM. Multiple drug resistance in human cancer. New Engl J Med 1987: 316: 1388-92
6. Faulk WP. Harats H. Berczi A. Transferrin receptor growth control in normal and transformed cells. In Crane FL, Morre DJ. Low HE. eds. Oxidoreduction at the plasma membrane: relation to growth and transport. Vol. I. Chapt 10. Boca Raton: CRC Press. 1990: 205-24
7. Faulk WP. Barabas K. Sun IL. Crane FL. Transferrinadriamycin conjugates which inhibit tumour cell proliferation without interaction with DNA inhibit plasma membrane oxidoreductase and proton release in K562 Cells. Biochem Int 1991; 25: 815-22
8. Seymour GJ, Walsh MD, Lavin MF, Strutton G, Gardiner RA. Transferrin receptor expression by human bladder transitional cell carcinoma. Urol Res 1987; 15: 341-4
9. Sun IL, Sun EE, Crane FL, Morre DJ. Faulk WP. Inhibition of transplasma membrane electron transport by transferrinadriamycin conjugates. Biochim Biophys Ada 1992; 1105: 84-8
10. Yaxley J, Watters D. Williams S, Lavin MF, Seymour GJ, Gardiner RA. Transferrin-adriamycin conjugate effects on T24 cells. Aust N X J Sun; 1995; 65: 518
11. Yeh C-JG, Faulk WP. Killing of human tumor cells in culture with adriamycin conjugates of human transferrin. Clin Immunol Immunopathol 1984: 32: 1-11
12. MrGraw Greenfleld L, Maxfield FR. Functional expression of the human transferrin receptor cDNA in Chinese hamster ovary cells deficient in endogenous transferrin receptor. J Cell Biol 1987: 105: 207-14
13. 3 Skehan P. Storeng R. Scudiero D ft al. New colorimetric cytotoxicity assay for anticancer-drug screening. J Natl Cancer Inst 1990: 82: 1107-12
14. Berczi A. Ruthner M, Szuts V. Fritzer M, Schweinzer E. Goldenberg H. Influence of conjugation of doxorubicin to transferrin on the iron uptake by K562 cells via receptormediated endocytosis. Eur J Biochem 1993: 213: 427-36
15. 5 Faulk WP, Taylor CG, Yeh C-JG, Mclntyre JA. Preliminary clinical study of transferrin-adriamycin conjugate for drug delivery to acute leukemia patients. Mol Biother 1990b: 2: 57-60
16. Barabas K, Sizensky J. Faulk PW. Transferrin conjugates of adriamycin are cytotoxic without intercalating nuclear DNA. J Biol Chem 1992: 267: 9437-42
17. Vrignaud P. Mantaudon D, Londos-Galiardi D, Robert J. Fatty acid composition, transport and metabolism in doxorubicin-sensitive and -resistant rat glioblastoma cells. Cancer Res 1986: 46: 3258-61
18. Tarasiuk J. Garnier-Suillerot A. Kinetic parameters for the uptake of anthracycline by drug-resistant and drug-sensitive K562 cells. Eur J Biochem 1992; 204: 693-8
19. Ferrer-Montiel AV, Gonzales-Ros JM, Ferragut JA. Different distribution of daunomycin in plasma membranes from drug-sensitive and drug-resistant P388-leukemia cells. Biochim Biophys Acta 1992: 1104: 111-6
20. Richardson DR. Baker E. Two saturable mechanisms of iron uptake from transferrin in human melanoma cells: the effect of transferrin concentration, chelators. and metabolic probes on transferrin and iron uptake. J Cell Physiol 1994: 161: 160-8
21. Klausner RD, Van Renswoude J. Ashwell G et al. Receptormediated endocytosis of transferrin in K 5 62 cells. J Biol Chem 1983: 258:4715-24